Overview

Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant

Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.
Phase:
N/A
Details
Lead Sponsor:
Norton Healthcare
Treatments:
Contraceptive Agents
Etonogestrel
Norethindrone
Norethindrone Acetate